glp-1 blood brain barrier uptake pharmacokinetics of incretin receptor agonists showing promise as Alzheimer's and Parkinson's disease therapeutics Mechanisms of GLP-1 in Modulating

Tirzepatide (Mounjaro) Tirzepatide is unique because it targets two hormones: GLP-1 and glucose-dependent insulinotropic polypeptide (GIP)

Mohamed, N

Medication Interactions Gastric Acid Inhibitors Gastric acid inhibitors include proton pump inhibitors, such as omeprazole (Prilosec) and lansoprazole (Prevacid), and histamine 2-receptor antagonists, such as cimetidine (Tagamet) and ranitidine (Zantac)

In the Actos Now for Prevention of Diabetes (ACT NOW) study, pioglitazone decreased the rate of conversion of subjects from having impaired glucose tolerance (IGT) to T2DM by 72% and significantly improved insulin sensitivity and -cell function [30]

Incretin-Based Drugs as Potential Therapy for Neurodegenerative Diseases: Current Status and Perspectives

Reviews the role of NAD+ biosynthesis pathways including the nicotinamide salvage pathway modulated by NNMT in cellular energy homeostasis and ageing